These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21287668)

  • 21. Eruptive melanocytic naevi provoked by sunbed use in a patient on systemic immunosuppression.
    O'Keeffe C; Hollywood A; Hanley B; Boggs J; Roche M; Feighery C
    Clin Exp Dermatol; 2020 Mar; 45(2):273-274. PubMed ID: 31389065
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammatory bowel disease treatment and non-melanoma skin cancer: a case report.
    De Luca JF; Lee YS; Johnson D
    Hawaii J Med Public Health; 2012 Nov; 71(11):324-5. PubMed ID: 23155491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease.
    Pola S; Boland BS; Lin GY; Kuo A; Sandborn WJ
    Dig Dis Sci; 2014 Jul; 59(7):1642-4. PubMed ID: 24535249
    [No Abstract]   [Full Text] [Related]  

  • 24. An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: we are willing to take a risk of serious adverse events for a doubtful benefit?
    Sinagra E; Romano C; Virdone R; Orlando E; Cottone M; Orlando A
    J Crohns Colitis; 2012 Oct; 6(9):954-5. PubMed ID: 22771136
    [No Abstract]   [Full Text] [Related]  

  • 25. Early combined immunosuppression in Crohn's disease.
    Lees CW; Satsangi J
    Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555905
    [No Abstract]   [Full Text] [Related]  

  • 26. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 28. Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report.
    Gibson DJ; Gallagher CG; Doherty GA
    J Crohns Colitis; 2014 Nov; 8(11):1561-2. PubMed ID: 24834815
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
    Griffiths AM
    Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
    [No Abstract]   [Full Text] [Related]  

  • 30. Varicella zoster meningoradiculitis in Crohn's disease treated with 6-mercaptopurine.
    Cullen G; Krakower D; Mitty JA; Cheifetz AS
    Inflamm Bowel Dis; 2011 Aug; 17(8):E109-10. PubMed ID: 21618366
    [No Abstract]   [Full Text] [Related]  

  • 31. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Herrlinger KR; Stange EF
    N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20825325
    [No Abstract]   [Full Text] [Related]  

  • 33. Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
    Panaccione R; Fedorak RN; Aumais G; Bernstein CN; Bitton A; Croitoru K; Enns R; Feagan B; Fishman M; Greenberg G; Griffiths A; Marshall JK; Rasul I; Sadowski D; Seidman E; Steinhart H; Sutherland L; Walli E; Wild G; Williams CN; Zachos M;
    Can J Gastroenterol; 2004 Aug; 18(8):503-8. PubMed ID: 15372114
    [No Abstract]   [Full Text] [Related]  

  • 34. Infliximab- and azathioprine-related severe neutropenia and thrombocytopenia in a case with Crohn's disease.
    Köksal AR; Alkim C; Altinkaya E; Buğdaci MS; Özdoğan O; Boğa S; Alkim H; Sökmen M
    Turk J Gastroenterol; 2011 Oct; 22(5):537-9. PubMed ID: 22234764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
    Burger DC; Florin TH
    Med J Aust; 2009 Mar; 190(6):341-2. PubMed ID: 19296822
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
    Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
    Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Gelber AC
    N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20848680
    [No Abstract]   [Full Text] [Related]  

  • 39. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy.
    Devlin SM; Hu B; Ippoliti A
    Dig Dis Sci; 2007 Sep; 52(9):2078-81. PubMed ID: 17406841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.